Gastric bypass surgery

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Results

By Mayo Clinic staff

In addition to dramatic weight loss, gastric bypass surgery may improve or resolve the following conditions associated with obesity:

  • Type 2 diabetes
  • High blood pressure
  • High blood cholesterol
  • Obstructive sleep apnea
  • Gastroesophageal reflux disease (GERD)

The improvements observed in type 2 diabetes, high blood pressure and high blood cholesterol may significantly decrease your risk of having a heart attack or stroke. Gastric bypass surgery can also improve your ability to get around, and improve your quality of life.

Surgery for weight reduction isn't a miracle procedure. It doesn't guarantee that you'll lose all of your excess weight or that you'll keep it off long term. Weight-loss success after gastric bypass surgery depends on your commitment to making lifelong changes in your eating and exercise habits. But the feeling of accomplishment as you lose weight and your improved health are significant benefits and are well worth your efforts.

Roux-en-Y gastric bypass surgery isn't considered to be reversible. While in theory it may be possible to reverse the changes in your digestive tract, it may be dangerous. If you're concerned about the reversibility of a gastric bypass procedure, talk to your doctor about your options.

References
  1. American Gastroenterological Association. American Gastroenterological Association medical position statement on obesity. Gastroenterology. 2002;123:879.
  2. Bariatric surgery for severe obesity. National Institute on Diabetes and Digestive and Kidney Diseases. http://win.niddk.nih.gov/publications/PDFs/gasurg12.04bw.pdf. Accessed Aug. 10, 2009.
  3. Mun EC, et al. Surgical management of severe obesity. http://www.uptodate.com/home/index.html. Accessed Aug. 10, 2009.
  4. Angrisiani L, et al. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surgery for Obesity and Related Diseases. 2007;3:127.
  5. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. New England Journal of Medicine. 2009;361:445.
  6. Suter M, et al. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: Similar body weight loss, correction of comorbidities, and improvement of quality of life. Archives of Surgery. 2009;144:312.
  7. Cottam D, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surgical Endoscopy. 2006;20:859.
  8. Mun EC, et al. Complications of bariatric surgery. http://www.uptodate.com/home/index.html. Accessed Aug. 10, 2009.

MY00825

Oct. 2, 2009

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger